LAUSR

In the FREEDOM trial, revascularization with CABG surgery was superior to percutaneous coronary intervention (PCI) with drugeluting stents in reducing the rate of major adverse cardiovascular events in patients with diabetes mellitus who have multivessel coronary artery disease (CAD). The FREEDOM FollowOn study, a 7.5 yearfollow up report of 943 of the 1,900 patients of the FREEDOM trial, now shows that patients with diabetes who underwent CABG surgery have greater longterm survival than patients treated with PCI, with an allcause mortality of 23.7% in the PCI group and 18.7% in the CABG surgery group. These results confirm the superiority of CABG surgery over PCI to treat patients with diabetes who have multivessel CAD, and support the current guidelines.